Serotonin receptors: Therapeutic prospects in cardiovascular disease
- 31 August 1991
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 1 (5) , 205-210
- https://doi.org/10.1016/1050-1738(91)90039-h
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- CARDIOVASCULAR EFFECTS FROM STIMULATION OF 5‐HYDROXYTRYPTAMINE RECEPTORSFundamental & Clinical Pharmacology, 1989
- Serotonin is localized in endothelial cells of coronary arteries and released during hypoxia: A possible new mechanism for hypoxia-induced vasodilatation of the rat heartCellular and Molecular Life Sciences, 1988
- Antiarrhythmic effect of a 5-hydroxytryptamine M-receptor antagonist, ICS 205-930The American Journal of Cardiology, 1988
- Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205–930Life Sciences, 1988
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological AnalysisJournal of Cardiovascular Pharmacology, 1987
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- Inhibition of noradrenaline (NA)-induced cardiac arrhythmias in the rat by ICS 205–930Journal of Molecular and Cellular Cardiology, 1984
- Indoleaminergic mechanisms in brain vessels; Localization, concentration, uptake and in vitro responses of 5-hydroxytryptamineActa Physiologica Scandinavica, 1984
- Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotoninNature, 1983